WallStreetZenWallStreetZen

NASDAQ: TTNP
Titan Pharmaceuticals Inc Earnings & Revenue

TTNP past revenue growth

How has TTNP's revenue growth performed historically?
Company
-46.5%
Industry
165.61%
Market
17.84%
TTNP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TTNP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TTNP's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TTNP earnings and revenue history

Current Revenue
$306.0k
Current Earnings
-$6.2M
Current Profit Margin
-2,014.7%

TTNP Return on Equity

Current Company
-302.6%
Current Industry
15.4%
Current Market
-8.4%
TTNP's Return on Equity (-302.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TTNP announces earnings.

TTNP Return on Assets

Current Company
-144.7%
Current Industry
2.2%
TTNP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TTNP Return on Capital Employed

Current Company
-75.35%
Current Industry
17.7%
TTNP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TTNP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TTNP$306.00k-$5.97M-$6.17M-43.76%N/A
SILO$72.10k-$3.70M-$3.70M+15.46%N/A
XCUR$23.79M$5.04M$3.07M+38.63%-72.96%
GMDA$1.78M-$60.97M-$63.00MN/AN/A
PALI$250.00k-$12.20M-$12.32M-0.78%N/A

Titan Pharmaceuticals Earnings & Revenue FAQ

What were TTNP's earnings last quarter?

On Invalid Date, Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2023 earnings per share (EPS) of -$0.40, up 88.89% year over year. Total Titan Pharmaceuticals earnings for the quarter were -$338.00 thousand. In the same quarter last year, Titan Pharmaceuticals's earnings per share (EPS) was -$3.60.

If you're new to stock investing, here's how to buy Titan Pharmaceuticals stock.

What was TTNP's earnings growth in the past year?

As of Q1 2024, Titan Pharmaceuticals's earnings has grown year over year. Titan Pharmaceuticals's earnings in the past year totalled -$6.17 million.

What was TTNP's revenue last quarter?

On Invalid Date, Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2023 revenue of $4.00 thousand up 95.79% year over year. In the same quarter last year, Titan Pharmaceuticals's revenue was $95.00 thousand.

What was TTNP's revenue growth in the past year?

As of Q1 2024, Titan Pharmaceuticals's revenue has grown -46.5% year over year. This is 212.11 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Titan Pharmaceuticals's revenue in the past year totalled $306.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.